Conditions

close

result 474 件

JaLCDOI 10.18926/AMO/65493
FullText URL 77_3_281.pdf
Author Mukai, Yuko| Taira, Naruto| Kajiwara, Yukiko| Iwamoto, Takayuki| Kitaguchi, Yohei| Saiga, Miho| Watanabe, Satoko| Shien, Tadahiko| Doihara, Hiroyoshi| Kimata, Yoshihiro|
Abstract Although immediate breast reconstruction following mastectomy has become increasingly common, its oncological safety has been debated. We enrolled patients with breast cancer who underwent surgery at Okayama University Hospital between 2007 and 2013. The primary outcome was relapse-free survival (RFS). Secondary outcomes were overall survival and the duration from the surgery to the initiation of adjuvant chemotherapy. We divided into immediate breast reconstruction, mastectomy alone, and breast conservative surgery groups. Outcomes were compared using Cox’s regression analysis. A total of 614 patients were included (reconstruction: 125, mastectomy: 128, breast conservative surgery: 361). The median follow-up duration was 79.0±31.9 months. The immediate-reconstruction patients were younger, had more lymph node metastases, and more often received postoperative chemotherapy. The RFS was better after the breast conservative surgery compared to after reconstruction (hazard ratio 0.33, 95% confidence interval: 0.144-0.763). The proportion of local recurrence was highest in the reconstruction group. No patients in the reconstruction group underwent postoperative radiation therapy. However, reconstruction did not affect overall survival or the time to the initiation of adjuvant chemotherapy. Surgeons should explain the risks of breast reconstruction to their patients preoperatively. Careful long-term follow-up is required after such procedures.
Keywords immediate breast reconstruction oncological safety local recurrence postoperative radiation therapy time to initiation of adjuvant chemotherapy
Amo Type Original Article
Publication Title Acta Medica Okayama
Published Date 2023-06
Volume volume77
Issue issue3
Publisher Okayama University Medical School
Start Page 281
End Page 290
ISSN 0386-300X
NCID AA00508441
Content Type Journal Article
language English
Copyright Holders Copyright Ⓒ 2023 by Okayama University Medical School
File Version publisher
Refereed True
PubMed ID 37357629
Web of Science KeyUT 001026279600006
FullText URL fulltext.pdf
Author Shiotani, Toshio| Sugimoto, Seiichiro| Tomioka, Yasuaki| Yamamoto, Haruchika| Tanaka, Shin| Miyoshi, Kentaroh| Suzawa, Ken| Shien, Kazuhiko| Yamamoto, Hiromasa| Okazaki, Mikio| Toyooka, Shinichi|
Keywords Biomarker Chronic lung allograft dysfunction Lung transplantation Living -donor lobar lung transplantation Micro-RNA
Published Date 2023-04
Publication Title Heliyon
Volume volume9
Issue issue4
Publisher Elsevier
Start Page e14903
ISSN 2405-8440
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © 2023 The Authors.
File Version publisher
PubMed ID 37025782
DOI 10.1016/j.heliyon.2023.e14903
Web of Science KeyUT 000998641100001
Related Url isVersionOf https://doi.org/10.1016/j.heliyon.2023.e14903
FullText URL K0006805_abstract_review.pdf K0006805_fulltext.pdf K0006805_summary.pdf
Author ZHU, YIDAN|
Published Date 2023-03-24
Content Type Thesis or Dissertation
Grant Number 甲第6805号
Granted Date 2023-03-24
Thesis Type Doctor of Philosophy in Medical Science
Grantor 岡山大学
language English
Copyright Holders © The Author(s), under exclusive licence to The Japanese Breast Cancer Society 2022
FullText URL K0006778_abstract_review.pdf K0006778_fulltext.pdf K0006778_other.pdf
Author LI, CHUNNING|
Published Date 2023-03-24
Content Type Thesis or Dissertation
Grant Number 甲第6778号
Granted Date 2023-03-24
Thesis Type Doctor of Philosophy in Medical Science
Grantor 岡山大学
language English
Copyright Holders © The Author(s) 2022.
FullText URL fulltext.pdf
Author Kawana, Shinichi| Miyoshi, Kentaroh| Tanaka, Shin| Sugimoto, Seiichiro| Shimizu, Dai| Matsubara, Kei| Okazaki, Mikio| Hattori, Noboru| Toyooka, Shinichi|
Keywords graft dysfunction immunosuppression lung transplantation pulmonary alveolar proteinosis
Published Date 2023-05-23
Publication Title Respirology Case Reports
Volume volume11
Issue issue6
Publisher Wiley
Start Page e01160
ISSN 2051-3380
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © 2023 The Authors.
File Version publisher
PubMed ID 37229297
DOI 10.1002/rcr2.1160
Web of Science KeyUT 000992419400001
Related Url isVersionOf https://doi.org/10.1002/rcr2.1160
FullText URL fulltext.pdf
Author Yamamoto, Shunki| Kosaki, Yoshinori| Uehara, Takenori| Naito, Hiromichi| Nakao, Atsunori|
Keywords case report breast hematoma chest injury seat belt injury traffic injury
Published Date 2023-02-25
Publication Title Cureus
Volume volume15
Issue issue2
Publisher Springer
Start Page e35440
ISSN 2168-8184
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © 2023 Yamamoto et al.
File Version publisher
PubMed ID 36994269
DOI 10.7759/cureus.35440
Web of Science KeyUT 000978767800001
Related Url isVersionOf https://doi.org/10.7759/cureus.35440
FullText URL fulltext.pdf
Author Akezaki, Yoshiteru| Nakata, Eiji| Kikuuchi, Masato| Sugihara, Shinsuke| Katayama, Yoshimi| Katayama, Haruyoshi| Hamada, Masanori| Ozaki, Toshifumi|
Keywords spinal bone metastases radiotherapy chemotherapy activities of daily living overall survival
Published Date 2022-02-11
Publication Title Healthcare
Volume volume10
Issue issue2
Publisher MDPI
Start Page 350
ISSN 2227-9032
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © 2022 by the authors.
File Version publisher
PubMed ID 35206964
DOI 10.3390/healthcare10020350
Web of Science KeyUT 000976128500003
Related Url isVersionOf https://doi.org/10.3390/healthcare10020350
FullText URL fulltext.pdf
Author Komalasari, Ni Luh Gede Yoni| Tomonobu, Nahoko| Kinoshita, Rie| Chen, Youyi| Sakaguchi, Yoshihiko| Gohara, Yuma| Jiang, Fan| Yamamoto, Ken-Ich| Murata, Hitoshi| Ruma, I Made Winarsa| Sumardika, I Wayan| Zhou, Jin| Yamauchi, Akira| Kuribayashi, Futoshi| Inoue, Yusuke| Toyooka, Shinichi| Sakaguchi, Masakiyo|
Keywords breast cancer lysyl oxidase annexin A2 integrin cancer microenvironment
Published Date 2023-04-04
Publication Title Frontiers in Oncology
Volume volume13
Publisher Frontiers Media
Start Page 1142907
ISSN 2234-943X
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © 2023 Komalasari, Tomonobu, Kinoshita, Chen, Sakaguchi, Gohara, Jiang, Yamamoto, Murata, Ruma, Sumardika, Zhou, Yamauchi, Kuribayashi, Inoue, Toyooka and Sakaguchi.
File Version publisher
PubMed ID 37091157
DOI 10.3389/fonc.2023.1142907
Web of Science KeyUT 000970195800001
Related Url isVersionOf https://doi.org/10.3389/fonc.2023.1142907
JaLCDOI 10.18926/AMO/65143
FullText URL 77_2_139.pdf
Author Namio, Keiichi| Kondo, Takashi| Miyatake, Nobuyuki| Hishii, Shuhei| Nishi, Hiroyuki| Katayama, Akihiko| Ujike, Kazuhiro| Suzuki, Hiromi| Koumoto, Kiichi|
Abstract We investigated the link between prolonged sedentary bouts and all-cause mortality in patients on chronic hemodialysis, using a prospective cohort. A total of 104 outpatients on chronic hemodialysis from 2013 to 2019, aged 71.4±11.4 years, were enrolled. Prolonged sedentary bouts (≥ 30 min and ≥60 min) (min and bouts) and relative prolonged sedentary bouts (≥ 30 min and ≥ 60 min) (%) on the patients’ non-hemodialysis days were measured by a tri-accelerometer, and we also analyzed the patients’ clinical parameters. The relationship between prolonged sedentary bouts and all-cause mortality was evaluated by a survival analysis and the Cox proportional hazard model. Thirty-five patients died during the follow-up period. A Kaplan-Meier analysis detected significant differences in the survival rate between two groups stratified by the median for all prolonged sedentary-bout parameters. After the adjustment for confounding factors, all of the prolonged sedentary-bout parameters were determinant factors for all-cause mortality. These results indicate that prolonged sedentary bouts on non-hemodialysis days were closely related to all-cause mortality in the patients on hemodialysis.
Keywords sedentary bout mortality hemodialysis survival analysis
Amo Type Original Article
Publication Title Acta Medica Okayama
Published Date 2023-04
Volume volume77
Issue issue2
Publisher Okayama University Medical School
Start Page 139
End Page 145
ISSN 0386-300X
NCID AA00508441
Content Type Journal Article
language English
Copyright Holders Copyright Ⓒ 2023 by Okayama University Medical School
File Version publisher
Refereed True
PubMed ID 37094951
Web of Science KeyUT 000982503800003
FullText URL fulltext.pdf
Author Hirabayashi, Daisuke| Yamamoto, Ken-ichi| Maruyama, Akihiro| Tomonobu, Nahoko| Kinoshita, Rie| Chen, Youyi| Komalasari, Ni Luh Gede Yoni| Murata, Hitoshi| Gohara, Yuma| Jiang, Fan| Zhou, Jin| Ruma, I. Made Winarsa| Sumardika, I. Wayan| Yamauchi, Akira| Kuribayashi, Futoshi| Toyooka, Shinichi| Inoue, Yusuke| Sakaguchi, Masakiyo|
Keywords epithelial-to-mesenchymal transition triple-negative breast cancer zinc ZEB1 metastasis
Published Date 2023-02-23
Publication Title Frontiers in Oncology
Volume volume13
Publisher Frontiers Media
Start Page 1142886
ISSN 2234-943X
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © 2023 Hirabayashi, Yamamoto, Maruyama, Tomonobu, Kinoshita, Chen, Komalasari, Murata, Gohara, Jiang, Zhou, Ruma, Sumardika, Yamauchi, Kuribayashi, Toyooka, Inoue and Sakaguchi.
File Version publisher
PubMed ID 36910659
DOI 10.3389/fonc.2023.1142886
Web of Science KeyUT 000945660600001
Related Url isVersionOf https://doi.org/10.3389/fonc.2023.1142886
FullText URL fulltext20230508-03.pdf
Author Hagiya, Hideharu| Hikita, Takao| Habu, Tomohiro| Asada, Masaki| Yorifuji, Takashi| Toyooka, Shinichi| Otsuka, Fumio| Nakayama, Masanori|
Note © 2022 The British Infection Association. This manuscript version is made available under the CC-BY-NC-ND 4.0 License. http://creativecommons.org/licenses/by-nc-nd/4.0/. This is the accepted manuscript version. The formal published version is available at https://doi.org/10.1016/j.jinf.2022.07.007. | This fulltext file will be available in Oct. 2023.|
Published Date 2022-10
Publication Title Journal of Infection
Volume volume85
Issue issue4
Publisher Elsevier
Start Page 436
End Page 480
ISSN 0163-4453
NCID AA00258231
Content Type Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © 2022 The British Infection Association.
File Version author
PubMed ID 35835411
DOI 10.1016/j.jinf.2022.07.007
Web of Science KeyUT 000883125700028
Related Url isVersionOf https://doi.org/10.1016/j.jinf.2022.07.007
JaLCDOI 10.18926/AMO/64360
FullText URL 77_1_37.pdf
Author Yamanouchi, Kosho| Maeda, Shigeto|
Abstract Systemic therapy for stage IV breast cancer is usually an initial treatment and is based on findings regarding biomarkers (e.g., hormone receptors and human epidermal growth factor receptor-2 [HER2]). However, the response to therapy and outcomes sometime differ among patients with similar prognostic factors including grade, hormone receptor, HER2, and more. We conducted retrospective analyses to evaluate the correlations between the overall survival (OS) of 46 stage IV breast cancer patients and (i) the peripheral absolute lymphocyte count (ALC) and (ii) composite blood cell markers. The peripheral blood cell markers included the neutrophil- to-lymphocyte ratio (NLR), the monocyte-to-lymphocyte ratio (MLR), the systemic immune-inflammation index (SII), the systemic inflammation response index (SIRI), and the most recently introduced indicator, the pan-immune-inflammatory value (PIV). The SIRI and PIV showed prognostic impacts on the patients: those with a low SIRI or a low PIV showed significantly better OS than those with a high SIRI (5-year, 66.0% vs. 35.0%, p<0.05) or high PIV (5-year, 68.1% vs. 38.5%, p<0.05), respectively. This is the first report indicating the possible prognostic value of the PIV for OS in patients with stage IV breast cancer. Further studies with larger numbers of patients are necessary for further clarification.
Keywords breast cancer pan-immune-inflammatory value prognosis
Amo Type Original Article
Publication Title Acta Medica Okayama
Published Date 2023-02
Volume volume77
Issue issue1
Publisher Okayama University Medical School
Start Page 37
End Page 43
ISSN 0386-300X
NCID AA00508441
Content Type Journal Article
language English
Copyright Holders Copyright Ⓒ 2023 by Okayama University Medical School
File Version publisher
Refereed True
PubMed ID 36849144
Web of Science KeyUT 000952992100001
JaLCDOI 10.18926/AMO/64356
FullText URL 77_1_11.pdf
Author Watanabe, Satoko| Saiga, Miho| Motoki, Takayuki| Shien, Tadahiko| Taira, Naruto| Doihara, Hiroyoshi| Kimata, Yoshihiro|
Abstract The importance of a well-fitted, comfortable brassiere to overall quality of life after breast reconstruction has not been evaluated. Our aim was to determine the impact of a semi-customized brassiere on patients’ health-related quality of life after breast reconstruction. The subjects were prospective patients with mastectomy who were to undergo immediate or delayed breast reconstruction at our hospital. After surgery, a professional bra fitter sized each patient for a semi-customized brassiere and provided follow-up consultations. A self-reported questionnaire on breast aesthetics, postoperative pain, and satisfaction was used to assess the primary outcomes. Data were prospectively collected at baseline (before surgery) and at 1, 3, 6, and 12 months after surgery and analyzed. Forty-six patients (50 breasts) were included in the analysis. Consistent wearing of the brassiere reduced pain (p<0.05), with good overall satisfaction (p<0.001). Aesthetic scores on breast shape and size were higher with than without the custom brassiere at 3 months (p=0.02) and 6 months (p=0.03) after surgery. Wearing the brassiere reduced anxiety at all time points of measurement. A well-fitting brassiere ensured safety and provided a high degree of satisfaction without anxiety for patients after breast reconstruction.
Keywords breast reconstruction mastectomy brassiere professional bra fitter
Amo Type Original Article
Publication Title Acta Medica Okayama
Published Date 2023-02
Volume volume77
Issue issue1
Publisher Okayama University Medical School
Start Page 11
End Page 19
ISSN 0386-300X
NCID AA00508441
Content Type Journal Article
language English
Copyright Holders Copyright Ⓒ 2023 by Okayama University Medical School
File Version publisher
Refereed True
PubMed ID 36849141
Web of Science KeyUT 000953663800002
FullText URL fulltext.pdf
Author Akezaki, Yoshiteru| Nakata, Eiji| Kikuuchi, Masato| Tominaga, Ritsuko| Kurokawa, Hideaki| Okamoto, Masaki| Ozaki, Toshifumi| Aogi, Kenjiro| Ohsumi, Shozo| Sugihara, Shinsuke|
Keywords breast cancer elderly comorbidity upper-limb function rehabilitation
Published Date 2023-01-04
Publication Title Current Oncology
Volume volume30
Issue issue1
Publisher MDPI
Start Page 673
End Page 680
ISSN 1198-0052
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © 2023 by the authors.
File Version publisher
PubMed ID 36661701
DOI 10.3390/curroncol30010052
Web of Science KeyUT 000914388100001
Related Url isVersionOf https://doi.org/10.3390/curroncol30010052
FullText URL fulltext.pdf
Author Wang, Yuze| Ohara, Toshiaki| Chen, Yuehua| Hamada, Yusuke| Li, Chunning| Fujisawa, Masayoshi| Yoshimura, Teizo| Matsukawa, Akihiro|
Keywords triple-negative breast cancer iron metabolism iron chelator phosphoinositide-3-kinase-protein kinase heterogeneity metastasis
Published Date 2023-01-12
Publication Title Cancers
Volume volume15
Issue issue2
Publisher MDPI
Start Page 468
ISSN 2072-6694
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © 2023 by the authors.
File Version publisher
PubMed ID 36672419
DOI 10.3390/cancers15020468
Web of Science KeyUT 000914513700001
Related Url isVersionOf https://doi.org/10.3390/cancers15020468
FullText URL fulltext.pdf
Author Iwatani, Tsuguo| Saito, Shinya|
Keywords parathyroid surgery prophylactic antibiotic risk factor surgical site infection thyroid surgery
Published Date 2022-12-11
Publication Title International Wound Journal
Volume volume2022
Publisher Wiley
ISSN 1742-4801
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © 2022 The Authors.
File Version publisher
PubMed ID 36504428
DOI 10.1111/iwj.14046
Web of Science KeyUT 000896886400001
Related Url isVersionOf https://doi.org/10.1111/iwj.14046
FullText URL fulltext20221223-3.pdf NA_Itano_Fig.pdf supl20221223-3.pdf NA_Itano_Supl.pdf
Author Itano, Junko| Taniguchi, Akihiko| Senoo, Satoru| Asada, Noboru| Gion, Yuka| Egusa, Yuria| Guo, Lili| Oda, Naohiro| Araki, Kota| Sato, Yasuharu| Toyooka, Shinichi| Kiura, Katsuyuki| Maeda, Yoshinobu| Miyahara, Nobuaki|
Keywords idiopathic pulmonary fibrosis NPY IL-1 beta; bleomycin bronchial epithelial cells
Note Originally Published in:Itano J, Taniguchi A, Senoo S, Asada N, Gion Y, Egusa Y, Guo L, Oda N, Araki K, Sato Y, Toyooka S, Kiura K, Maeda Y, Miyahara N. Neuropeptide Y Antagonizes Development of Pulmonary Fibrosis through IL-1β Inhibition. Am J Respir Cell Mol Biol. 2022 Dec;67(6):654-665.
DOI: 10.1165/rcmb.2021-0542OC
Copyright © 2022 by the American Thoracic Society
The final publication is available at https://doi.org/10.1165/rcmb.2021-0542OC |
This full-text will be available in Dec. 2023.|
Published Date 2022-12
Publication Title American Journal of Respiratory Cell and Molecular Biology
Volume volume67
Issue issue6
Publisher American Thoracic Society
Start Page 654
End Page 665
ISSN 1044-1549
NCID AA10707251
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © 2022 by the American Thoracic Society
File Version author
PubMed ID 36122332
DOI 10.1165/rcmb.2021-0542oc
Web of Science KeyUT 000891796900010
Related Url isVersionOf https://doi.org/10.1165/rcmb.2021-0542oc
FullText URL fulltext.pdf
Author Nakata, Kentaro| Okazaki, Mikio| Sakaue, Tomohisa| Kinoshita, Rie| Komoda, Yuhei| Shimizu, Dai| Yamamoto, Haruchika| Tanaka, Shin| Suzawa, Ken| Shien, Kazuhiko| Miyoshi, Kentaroh| Yamamoto, Hiromasa| Ohara, Toshiaki| Sugimoto, Seiichiro| Yamane, Masaomi| Matsukawa, Akihiro| Sakaguchi, Masakiyo| Toyooka, Shinichi|
Keywords ischemia reperfusion injury S100A8/A9 lung transplantation damage-associated molecule patterns
Published Date 2022-11-10
Publication Title Bioengineering
Volume volume9
Issue issue11
Publisher MDPI
Start Page 673
ISSN 2306-5354
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © 2022 by the authors.
File Version publisher
PubMed ID 36354584
DOI 10.3390/bioengineering9110673
Web of Science KeyUT 000880897200001
Related Url isVersionOf https://doi.org/10.3390/bioengineering9110673
JaLCDOI 10.18926/AMO/64119
FullText URL 76_6_689.pdf
Author Yamanouchi, Kosho| Kuba, Sayaka| Matsumoto, Megumi| Yano, Hiroshi| Morita, Michi| Sakimura, Chika| Otsubo, Ryota| Hidaka, Masaaki| Nagayasu, Takeshi| Eguchi, Susumu|
Abstract Taxanes are key drugs for patients with breast cancer. A major adverse effect of taxanes is peripheral neuropathy (PN). To investigate the ability of compression therapy using sleeves and stockings to prevent PN due to the taxane docetaxel, we conducted a single-center historical control trial. Patients receiving docetaxel at 75 mg/m2 every 3 weeks for 4 cycles as first-line chemotherapy for breast cancer were eligible. PN was evaluated using the common terminology criteria for adverse events version 4.0. The primary endpoint was the incidence of allgrade PN until 3 weeks after the fourth docetaxel administration. We evaluated 26 patients in the intervention group and compared their data to those collected retrospectively from 52 patients treated with docetaxel without compression. Neither the incidence of all-grade PN until 3 weeks after the fourth docetaxel administration (63.5% in the control group vs. 76.9% in the intervention group, p=0.31) nor that of PN grade ≥ 2 (13.5% vs. 15.4%, p=0.99) differed between the groups. In this study, the efficacy of compression therapy using sleeves and stockings to prevent PN induced by docetaxel was not demonstrated. Further clinical studies including medications or intervention are needed to reduce the incidence and severity of PN induced by chemotherapy.
Keywords breast cancer docetaxel neuropathy compression
Amo Type Original Article
Publication Title Acta Medica Okayama
Published Date 2022-12
Volume volume76
Issue issue6
Publisher Okayama University Medical School
Start Page 689
End Page 694
ISSN 0386-300X
NCID AA00508441
Content Type Journal Article
language English
Copyright Holders Copyright Ⓒ 2022 by Okayama University Medical School
File Version publisher
Refereed True
PubMed ID 36549771
Web of Science KeyUT 000905195100009
JaLCDOI 10.18926/AMO/64116
FullText URL 76_6_661.pdf
Author Abe, Yuko| Taira, Naruto| Kashiwabara, Kosuke| Tsurutani, Junji| Kitada, Masahiro| Takahashi, Masato| Kato, Hiroaki| Kikawa, Yuichiro| Sakata, Eiko| Naito, Yoichi| Hasegawa, Yoshie| Saito, Tsuyoshi| Iwasa, Tsutomu| Takashima, Tsutomu| Aihara, Tomohiko| Mukai, Hirofumi| Hara, Fumikata| Shien, Tadahiko| Doihara, Hiroyoshi| Toyooka, Shinichi|
Abstract Chemotherapy-induced peripheral neuropathy (CIPN) is an important clinical challenge that threatens patients’ quality of life. This sub-study of the ABROAD trial investigated the influence of single nucleotide polymorphisms (SNPs) on CIPN, using genotype data from a randomized study to determine the optimal dose of a 3-week-cycle regimen of nab-paclitaxel (q3w nab-PTX) in patients with metastatic breast cancer (MBC). Patients with HER2-negative MBC were randomly assigned to three doses of q3w nab-PTX (SD: 260 mg/m2 vs. MD: 220 mg/m2 vs. LD: 180 mg/m2). Five SNPs (EPHA4-rs17348202, EPHA5-rs7349683, EPHA6-rs301927, LIMK2-rs5749248, and XKR4-rs4737264) were analyzed based on the results of a previous genome-wide association study. Per-allele SNP associations were assessed by a Cox regression to model the cumulative dose of nab-PTX up to the onset of severe or worsening sensory neuropathy. A total of 141 patients were enrolled in the parent study; 91(65%) were included in this sub-study. Worsening of CIPN was significantly greater in the cases with XKR4 AC compared to those with a homozygote AA (HR 1.86, 95%CI: 1.00001−3.46, p=0.049). There was no significant correlation of CIPN with any other SNP. A multivariate analysis showed that the cumulative dose of nab-PTX was most strongly correlated with CIPN (p<0.01).
Keywords metastatic breast cancer taxane-induced peripheral neuropathy chemotherapy-induced peripheral neuropathy nab-paclitaxel single nucleotide polymorphism
Amo Type Original Article
Publication Title Acta Medica Okayama
Published Date 2022-12
Volume volume76
Issue issue6
Publisher Okayama University Medical School
Start Page 661
End Page 671
ISSN 0386-300X
NCID AA00508441
Content Type Journal Article
language English
Copyright Holders Copyright Ⓒ 2022 by Okayama University Medical School
File Version publisher
Refereed True
PubMed ID 36549768
Web of Science KeyUT 000905195100006